11(13)-DehydroivaxillinCAS# 87441-73-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 87441-73-4 | SDF | Download SDF |
PubChem ID | 435723 | Appearance | Powder |
Formula | C15H20O4 | M.Wt | 264.3 |
Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC12CCC3C(O3)(CC4C(CC1O2)C(=C)C(=O)O4)C | ||
Standard InChIKey | SSZZFAJCDFWCJW-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 11(13)-Dehydroivaxillin possesses a promising antiplasmodial activity, which can be exploited in malaria therapy. |
Targets | Antifection |
11(13)-Dehydroivaxillin Dilution Calculator
11(13)-Dehydroivaxillin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7836 mL | 18.9179 mL | 37.8358 mL | 75.6716 mL | 94.5895 mL |
5 mM | 0.7567 mL | 3.7836 mL | 7.5672 mL | 15.1343 mL | 18.9179 mL |
10 mM | 0.3784 mL | 1.8918 mL | 3.7836 mL | 7.5672 mL | 9.4589 mL |
50 mM | 0.0757 mL | 0.3784 mL | 0.7567 mL | 1.5134 mL | 1.8918 mL |
100 mM | 0.0378 mL | 0.1892 mL | 0.3784 mL | 0.7567 mL | 0.9459 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Viteralone
Catalog No.:BCN4419
CAS No.:87440-75-3
- 6-Dehydroxy-8-hydroxygaleopsinolone
Catalog No.:BCN7402
CAS No.:87440-66-2
- Glepidotin B
Catalog No.:BCN4844
CAS No.:87440-56-0
- Millewanin H
Catalog No.:BCN6465
CAS No.:874303-34-1
- Millewanin G
Catalog No.:BCN6461
CAS No.:874303-33-0
- Liriopesides B
Catalog No.:BCN2811
CAS No.:87425-34-1
- Daphnilongeranin A
Catalog No.:BCN4418
CAS No.:874201-05-5
- RO4987655
Catalog No.:BCC5135
CAS No.:874101-00-5
- Euchrestaflavanone B
Catalog No.:BCN6838
CAS No.:87402-91-3
- Denudatin B
Catalog No.:BCN4558
CAS No.:87402-88-8
- 2,3-Dihydroamentoflavone 7,4'-dimethyl ether
Catalog No.:BCN1320
CAS No.:873999-88-3
- Neotriangularine
Catalog No.:BCN2052
CAS No.:87392-67-4
- SEN 12333
Catalog No.:BCC6182
CAS No.:874450-44-9
- Schizanrin L
Catalog No.:BCN3620
CAS No.:874472-16-9
- (25RS)-Ruscogenin
Catalog No.:BCN7805
CAS No.:874485-32-2
- H-Arg-OtBu.2HCl
Catalog No.:BCC2862
CAS No.:87459-72-1
- Liriope muscari baily saponins C
Catalog No.:BCN2340
CAS No.:87480-46-4
- Dihydroajugapitin
Catalog No.:BCN4421
CAS No.:87480-84-0
- Toceranib phosphate
Catalog No.:BCC2006
CAS No.:874819-74-6
- Isamoltane hemifumarate
Catalog No.:BCC6879
CAS No.:874882-92-5
- L-741,742 hydrochloride
Catalog No.:BCC5696
CAS No.:874882-93-6
- LY2183240
Catalog No.:BCC1718
CAS No.:874902-19-9
- ZK 756326
Catalog No.:BCC7413
CAS No.:874911-96-3
- Boc-D-Cys(Trt)-OH
Catalog No.:BCC3381
CAS No.:87494-13-1
In vivo antiplasmodial activity of 11(13)-dehydroivaxillin from Carpesium ceruum.[Pubmed:18608780]
J Enzyme Inhib Med Chem. 2009 Feb;24(1):247-50.
The whole plants of Carpesium genus are used in traditional medicine as anti-pyretic, analgesic and vermifugic, including a topical application for sores and inflammation. A previous study on Carpesium genus suggested that the antiplasmodial activity against Plasmodium falciparum was due to the existence of 11(13)- dehydroivaxillin (DDV) from EtOAc extracts of C. ceruum (Compositae). Here, the antimalarial activity of DDV was evaluated against Plasmodium berghei in mice. The LD(50) of the compound was determined as 51.2 mg/kg, while doses of 124 mg/kg and above were found to be lethal to mice. DDV (2, 5, 10 mg/kg/day) exhibited a significant blood schizontocidal activity in 4-day early infection, repository evaluation and in an established infection with a significant mean survival time comparable to that of the standard drug, chloroquine, 5 mg/kg/day. DDV possesses a promising antiplasmodial activity, which can be exploited in malaria therapy.